JP2023553354A5 - - Google Patents
Info
- Publication number
- JP2023553354A5 JP2023553354A5 JP2023532250A JP2023532250A JP2023553354A5 JP 2023553354 A5 JP2023553354 A5 JP 2023553354A5 JP 2023532250 A JP2023532250 A JP 2023532250A JP 2023532250 A JP2023532250 A JP 2023532250A JP 2023553354 A5 JP2023553354 A5 JP 2023553354A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical product
- subject
- sad
- fear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118121P | 2020-11-25 | 2020-11-25 | |
| US202063118132P | 2020-11-25 | 2020-11-25 | |
| US63/118,132 | 2020-11-25 | ||
| US63/118,121 | 2020-11-25 | ||
| US202163158449P | 2021-03-09 | 2021-03-09 | |
| US63/158,449 | 2021-03-09 | ||
| PCT/US2021/060720 WO2022115526A1 (en) | 2020-11-25 | 2021-11-24 | Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine receptor agonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553354A JP2023553354A (ja) | 2023-12-21 |
| JP2023553354A5 true JP2023553354A5 (https=) | 2024-12-03 |
Family
ID=78957498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532250A Pending JP2023553354A (ja) | 2020-11-25 | 2021-11-24 | アルファ－７ニコチン性アセチルコリン受容体アゴニストを用いた、スピーチ不安の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230381169A1 (https=) |
| EP (1) | EP4251158A1 (https=) |
| JP (1) | JP2023553354A (https=) |
| KR (1) | KR20230112622A (https=) |
| AU (1) | AU2021387993A1 (https=) |
| CA (1) | CA3199760A1 (https=) |
| MX (1) | MX2023005895A (https=) |
| WO (1) | WO2022115526A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0220581D0 (en) * | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
| GB0424564D0 (en) * | 2004-11-05 | 2004-12-08 | Novartis Ag | Organic compounds |
| JP6263469B2 (ja) | 2011-07-15 | 2018-01-17 | ノバルティス アーゲー | アザ二環式ジ−アリールエーテルの塩およびその製造方法またはその前駆体の製造方法 |
| EP2742940B1 (en) * | 2012-12-13 | 2017-07-26 | IP Gesellschaft für Management mbH | Fumarate salt of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-l-aza-bicyclo-[2.2.2]octane for adminstration once daily, twice daily or thrice daily |
-
2021
- 2021-11-24 JP JP2023532250A patent/JP2023553354A/ja active Pending
- 2021-11-24 KR KR1020237016855A patent/KR20230112622A/ko active Pending
- 2021-11-24 CA CA3199760A patent/CA3199760A1/en active Pending
- 2021-11-24 WO PCT/US2021/060720 patent/WO2022115526A1/en not_active Ceased
- 2021-11-24 AU AU2021387993A patent/AU2021387993A1/en active Pending
- 2021-11-24 MX MX2023005895A patent/MX2023005895A/es unknown
- 2021-11-24 US US18/249,920 patent/US20230381169A1/en active Pending
- 2021-11-24 EP EP21827781.2A patent/EP4251158A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (https=) | ||
| JPWO1993011765A1 (ja) | （＋）アポビンカミン酸２−ニトロキシエチルエステルの新規な用途 | |
| JP2010523587A5 (https=) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| WO2018193648A1 (ja) | アルカリ性化剤による血液浄化 | |
| JP2022549834A5 (https=) | ||
| KR20240032789A (ko) | 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물 | |
| WO2007046347A1 (ja) | 筋萎縮性側索硬化症患者の運動神経保護用医薬 | |
| JP6509729B2 (ja) | 慢性腎臓病の進行抑制又は改善剤 | |
| JP2022553888A5 (https=) | ||
| JP2023553354A5 (https=) | ||
| Schiffl et al. | Clinical features and management of nifedipine overdosage in a patient with renal insufficiency | |
| JP2023544249A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| KR100692235B1 (ko) | 안지오텐신 ⅱ 길항물질의 신규한 용도 | |
| Lesar et al. | Trazodone overdose | |
| CA3076180C (en) | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression | |
| CN116171151A (zh) | 用于治疗病毒感染的pde3抑制剂 | |
| JPH05163145A (ja) | 脳血管性痴呆改善剤 | |
| RU2283097C2 (ru) | Способ лечения бронхиальной астмы, сочетанной с эрозивно-язвенными поражениями гастродуоденальной зоны | |
| Conway et al. | The place of methyldopa in the treatment of severe hypertension | |
| JP2004535457A (ja) | ピリダジノン誘導体の新しい用途 | |
| JP2024521354A5 (ja) | 多剤混合薬又は医薬組成物 | |
| JP2023542701A5 (https=) | ||
| JP2023507764A5 (https=) |